This project focuses on addressing heart failure caused by systolic dysfunction, which is a major contributor to global heart disease-related deaths. The proposed solution involves transplanting ventricular myocytes derived from allogeneic iPS cells to restore heart function, aiming for a radical and effective treatment of systolic heart failure.

Basic information

Country

JAPAN

Group Name

Heartseed Inc.

Source

Source